Used primarily as an intermediate in the synthesis of β-adrenergic receptor agonists, particularly in the production of bronchodilators for treating respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its chiral structure makes it valuable in asymmetric synthesis, where stereochemistry is critical for the biological activity of the final pharmaceutical product. It is also employed in the development of cardiovascular drugs due to its structural similarity to adrenergic agents. The compound's hydroxyl and amine functional groups allow for versatile chemical modifications, facilitating its incorporation into more complex drug molecules.